×
ADVERTISEMENT

NOVEMBER 17, 2022

FDA: Risks to Patients Exposed to Xylazine in Illicit Drugs

By PPN News Staff

The number of reports about serious adverse events (AEs) among patients exposed to fentanyl, heroin and other illicit drugs contaminated with xylazine are increasing, according to the FDA, which issued a warning to healthcare providers.

Stimulants (e.g., methamphetamine and cocaine) also have been combined with xylazine. Xylazine-containing products may be sold under the street names tranq, tranq dope, sleep-cut, Philly dope and zombie drug. There have been reports of